Elizabeth Challenger

The development and validation of a novel LC-MS/MS method for the quantification of Cenicriviroc in human plasma and cerebrospinal fluid.

A. Winston, S. Khoo, L. Else, 2019, Biomedical chromatography : BMC.

Cerebrospinal fluid exposure of cenicriviroc in HIV‐positive individuals with cognitive impairment

A. Winston, S. Khoo, L. Else, 2019, British journal of clinical pharmacology.

Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.

L. Myer, S. Khoo, C. Orrell, 2018, Bioanalysis.

The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma.

S. Khoo, M. Boffito, D. Back, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

S. Khoo, C. Herrera, J. Fox, 2021, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients

B. Clotet, S. Khoo, A. Curran, 2018, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.

S. Khoo, A. Owen, M. Boffito, 2019, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers

S. Khoo, A. Owen, M. Boffito, 2018, The Journal of antimicrobial chemotherapy.

Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma.

S. Khoo, H. Reynolds, J. Chiong, 2023, Journal of pharmaceutical and biomedical analysis.